Skip to main content

Currently Skimming:

References
Pages 103-112

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 103...
... 2023. GLP-1 receptor agonists and related mental health issues; Insights from a range of social media platforms using a mixed-methods approach.
From page 104...
... U.S. Food and Drug Administration.
From page 105...
... FDA (U.S. Food and Drug Administration)
From page 106...
... 2013. Associations between obesity and comorbid mental health, developmental, and physical health conditions in a nationally representa tive sample of U.S.
From page 107...
... 2017. The effect of intentional weight loss on fracture risk in persons with diabetes: Results from the Look AHEAD randomized clinical trial.
From page 108...
... 2013. The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys.
From page 109...
... U.S. Food and Drug Administration.
From page 110...
... 2021. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial.
From page 111...
... 2021. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: The STEP 3 randomized clinical trial.
From page 112...
... New England Journal of Medicine 384(11)


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.